# Todd S. Crocenzi

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/todd-s-crocenzi/

## Facts

| Field | Value |
| --- | --- |
| Citations | 26,718 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 31 |
| i10-index | 46 |
| OpenAlex ID | https://openalex.org/A5079825829 |
| ORCID iD | https://orcid.org/0000-0001-8762-1990 |
| Works | 105 |

## Researcher papers

- [PD-1 Blockade in Tumors with Mismatch-Repair Deficiency](https://scholariq.org/papers/pd-1-blockade-in-tumors-with-mismatch-repair-deficiency/)
- [Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade](https://scholariq.org/papers/mismatch-repair-deficiency-predicts-response-of-solid-tumors-to-pd-1-blockade/)
- [Safety and Survival With GVAX Pancreas Prime and <i>Listeria Monocytogenes</i>–Expressing Mesothelin (CRS-207) Boost Vaccines for Metastatic Pancreatic Cancer](https://scholariq.org/papers/safety-and-survival-with-gvax-pancreas-prime-and-i-listeria-monocytogenes-i/)
- [Expert Consensus Document on Pulmonary Metastasectomy](https://scholariq.org/papers/expert-consensus-document-on-pulmonary-metastasectomy/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.